Suppr超能文献

老年期双相障碍的生物标志物:基于证据的系统评价。

Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review.

机构信息

PSNREC, Univ Montpellier, INSERM, CHU de Montpellier, Montpellier, France.

Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, CHU Montpellier, Montpellier, France.

出版信息

Curr Psychiatry Rep. 2024 Mar;26(3):78-103. doi: 10.1007/s11920-024-01483-7. Epub 2024 Mar 12.

Abstract

PURPOSE OF REVIEW

Review the current evidence on biomarkers for bipolar disorder in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and Web of Science databases using the MeSH search terms "Biomarkers", "Bipolar Disorder", "Aged" and and "Aged, 80 and over". Studies were included if they met the following criteria: (1) the mean age of the study population was 50 years old or older, (2) the study included patients with bipolar disorder, and (3) the study examined one type of biomarkers or more including genetic, neuroimaging, and biochemical biomarkers. Reviews, case reports, studies not in English and studies for which no full text was available were excluded. A total of 26 papers were included in the final analysis.

RECENT FINDINGS

Genomic markers of bipolar disorder in older adults highlighted the implication of serotonin metabolism, while the expression of genes involved in angiogenesis was dysregulated. Peripheral blood markers were mainly related with low grade inflammation, axonal damage, endothelial dysfunction, and the dysregulation of the HPA axis. Neuroanatomical markers reflected a dysfunction of the frontal cortex, a loss of neurones in the anterior cingulate cortex and a reduction of the hippocampal volume (in patients older than 50 years old). While not necessarily limited to older adults, some of them may be useful for differential diagnosis (neurofilaments), disease staging (homocysteine, BDNF) and the monitoring of treatment outcomes (matrix metalloproteinases). Our review provides a comprehensive overview of the current evidence on biomarkers for bipolar disorder in the older adults. The identification of biomarkers may aid in the diagnosis, treatment selection, and monitoring of bipolar disorder in older adults, ultimately leading to improved outcomes for this population. Further research is needed to validate and further explore the potential clinical utility of biomarkers in this population.

摘要

目的综述

综述老年人群中双相情感障碍的生物标志物的现有证据。我们使用 MeSH 搜索词“生物标志物”、“双相情感障碍”、“老年人”和“80 岁及以上的老年人”,对 PubMed MEDLINE、PsycINFO 和 Web of Science 数据库进行了系统检索。如果研究符合以下标准,则将其纳入:(1)研究人群的平均年龄为 50 岁或以上,(2)研究包括双相情感障碍患者,(3)研究检查了一种或多种生物标志物,包括遗传、神经影像学和生化标志物。综述、病例报告、非英文研究以及无法获取全文的研究均被排除在外。共有 26 篇论文纳入最终分析。

最近的发现

老年人群中双相情感障碍的基因组生物标志物强调了 5-羟色胺代谢的影响,而涉及血管生成的基因表达则失调。外周血标志物主要与低度炎症、轴突损伤、内皮功能障碍和 HPA 轴失调有关。神经解剖学标志物反映了额叶皮层的功能障碍、前扣带皮层神经元的丧失以及海马体积的减少(在年龄大于 50 岁的患者中)。虽然这些标志物不一定仅限于老年人,但其中一些可能对鉴别诊断(神经丝)、疾病分期(同型半胱氨酸、BDNF)和治疗结果监测(基质金属蛋白酶)有用。我们的综述提供了老年人群中双相情感障碍生物标志物的现有证据的全面概述。生物标志物的识别可能有助于老年人群中双相情感障碍的诊断、治疗选择和监测,最终改善该人群的预后。需要进一步的研究来验证和进一步探索生物标志物在该人群中的潜在临床应用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验